In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma

DOI 2 Citations

Journal

  • Haematologica

    Haematologica 95 (5), 794-803, 2009-11-30

    Ferrata Storti Foundation (Haematologica)

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top